Korean Drug Co., Ltd. (KOSDAQ:014570)

South Korea · Delayed Price · Currency is KRW

3,405.00

+5.00 (0.15%)

At close: Aug 21, 2026

Korean Drug Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	65,390	62,509	73,001	81,375	79,984	74,466
Revenue Growth	4.22%	-14.37%	-10.29%	1.74%	7.41%	11.49%
Gross Profit	28,801	26,601	34,401	37,350	34,517	31,065
Operating Income	7,702	6,913	4,105	6,720	14,329	11,266
Net Income	1,482	6,512	2,995	-4,917	11,809	9,042
Earnings Per Share	-	601.97	277.55	-455.98	1095.09	827.64
EPS Growth	-	116.89%	-	-	32.31%	22.18%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	36,397	29,996	19,000	16,756	26,416	27,881
Total Debt	81.67	57.84	80.97	67.57	81.2	54.07
Net Cash (Debt)	36,315	29,939	18,919	16,688	26,335	27,826
Net Cash Growth	43.85%	58.25%	13.37%	-36.63%	-5.36%	25.47%
Net Cash Per Share	-	2767.49	1753.14	1547.64	2442.18	2546.94

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	13,212	13,110	4,869	-1,999	5,913	8,806
Capital Expenditures	-251.55	-457	-1,027	-120.7	-6,093	-1,146
Free Cash Flow	12,960	12,653	3,842	-2,119	-180.15	7,660
Free Cash Flow Growth	45.10%	229.34%	-	-	-	-33.92%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	44.05%	42.55%	47.12%	45.90%	43.16%	41.72%
Operating Margin	11.78%	11.06%	5.62%	8.26%	17.91%	15.13%
Pretax Margin	13.38%	12.47%	6.84%	10.16%	18.36%	15.20%
Profit Margin	2.27%	10.42%	4.10%	-6.04%	14.76%	12.14%
FCF Margin	19.82%	20.24%	5.26%	-2.60%	-0.22%	10.29%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	25.08	7.21	16.74	-	7.24	10.78
P/FCF Ratio	2.87	3.71	13.05	-	-	12.72
PS Ratio	0.57	0.75	0.69	0.96	1.07	1.31